Cover Picture.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 1, doi. 10.1002/dta.3913
- Publication type:
- Article
Works matching IS 1942-7603 AND VI 17 AND IP 6 AND DT 2025
Results: 22
1
2
Evaluation of Minimum Reporting Limits to Determine In‐Competition Use of Stimulants.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 915, doi. 10.1002/dta.3799
- By:
- Publication type:
- Article
3
Rapid Analytical Method for Quantification of Gamma‐Hydroxybutyrate (GHB) in Hair by UPLC‐MS/MS.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 903, doi. 10.1002/dta.3798
- By:
- Publication type:
- Article
4
Step‐By‐Step Procedure to Identify Previously Unknown Compounds by LC‐QTOF‐MS Exemplified by an Intoxication With the Methaqualone Analog SL‐164.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 897, doi. 10.1002/dta.3792
- By:
- Publication type:
- Article
5
Human phase‐I metabolism of three synthetic cannabinoids bearing a cumyl moiety and a cyclobutyl methyl or norbornyl methyl tail: Cumyl‐CBMEGACLONE, Cumyl‐NBMEGACLONE, and Cumyl‐NBMINACA.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 882, doi. 10.1002/dta.3791
- By:
- Publication type:
- Article
6
Changing trends in anabolic‐androgenic steroid use within Scottish prisons: Detection, prevalence, and quantitation.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 858, doi. 10.1002/dta.3790
- By:
- Publication type:
- Article
7
An NMR study on the keto‐enol tautomerism of 1,3‐dicarbonyl drug precursors.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 850, doi. 10.1002/dta.3789
- By:
- Publication type:
- Article
8
Characterization of the thyroid hormones level in urine by liquid chromatography coupled to mass spectrometry focus in the antidoping field.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 868, doi. 10.1002/dta.3788
- By:
- Publication type:
- Article
9
Beta<sub>2</sub>‐adrenergic agonist salbutamol exhibits enantioselective disposition in skeletal muscle of lean young men following oral administration.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 842, doi. 10.1002/dta.3787
- By:
- Publication type:
- Article
10
Identification of human metabolites of fast skeletal troponin activators Tirasemtiv and Reldesemtiv for doping control purposes.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 812, doi. 10.1002/dta.3786
- By:
- Publication type:
- Article
11
Enhanced analysis of equine plasma for the presence of recombinant human erythropoietin — Implementation of an improved workflow.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 786, doi. 10.1002/dta.3785
- By:
- Publication type:
- Article
12
Interlaboratory comparison of phosphatidylethanol in dried blood spots using different sampling devices.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 834, doi. 10.1002/dta.3784
- By:
- Publication type:
- Article
13
In vivo comparative study of hemp straw exposure and cannabidiol oil administration in horse urine.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 805, doi. 10.1002/dta.3783
- By:
- Publication type:
- Article
14
Metabolism study of 3‐chloromethcathinone (3‐CMC) by dried blood spot (DBS) sampling after controlled administration using a murine model.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 772, doi. 10.1002/dta.3782
- By:
- Publication type:
- Article
15
Quantitative analysis of nonsteroidal anti‐inflammatory drugs in dried blood spot from mountain ultra‐trail runners. Contribution of pharmacokinetic models for the interpretation of the results.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 825, doi. 10.1002/dta.3781
- By:
- Publication type:
- Article
16
Evaluation of spectroscopic techniques for on‐site drug testing of festival seizures.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 796, doi. 10.1002/dta.3780
- By:
- Publication type:
- Article
17
Determination of amphetamines in hair samples using microextraction by packed sorbent and gas chromatography–mass spectrometry.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 761, doi. 10.1002/dta.3779
- By:
- Publication type:
- Article
18
High‐throughput liquid chromatography‐vacuum differential mobility spectrometry‐mass spectrometry for the analysis of isomeric drugs of abuse in human urine.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 751, doi. 10.1002/dta.3778
- By:
- Publication type:
- Article
19
Mercaptans in malodorants break disulfide bridges in human serum albumin and form adducts suitable as biomarkers of exposure in vitro.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 722, doi. 10.1002/dta.3776
- By:
- Publication type:
- Article
20
Interest of hair tests to discriminate a tail end of a doping regimen from a possible contamination in case of challenging an anti‐doping rule violation. V. Case reports involving trimetazidine, a drug where the concentration after a single 20 mg dose has been established
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 779, doi. 10.1002/dta.3775
- By:
- Publication type:
- Article
21
Development and validation of general plasma screening method for performance enhancing drugs in racehorses utilizing liquid chromatography–high‐resolution mass spectrometry (LC–HRMS).
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 735, doi. 10.1002/dta.3774
- By:
- Publication type:
- Article
22
Issue Information.
- Published in:
- Drug Testing & Analysis, 2025, v. 17, n. 6, p. 713, doi. 10.1002/dta.3722
- Publication type:
- Article